• Home >>
  • Pharmaceuticals and Healthcare >>
  • Biosimilars Market - Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis and Competitive Analysis 2017 - 2025

Biosimilars Market - Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis and Competitive Analysis 2017 - 2025

ID: 47131 January, 2018 Region : Global Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Biosimilars Market with our analysts monitoring the situation across the globe.

Market Overview Biosimilars are the medical products which are almost an identical copy of the original product. These are the officially approved versions of original products that can be produced when the patent of original product expires. These are also known as biologics. These products exhibit high molecular complexity and are quite sensitive to changes during manufacturing processes. These biosimilar primarily consist of vaccine, recombinant proteins and diagnostics, hepatitis B vaccine and erythropoietin, granulocyte colony stimulating factor and interferons and other. Market Growth Factors In the current scenario of impending patent expiry on leading biological therapies that are used in oncology, and increasing financial constraints on healthcare system, these products offer an considerable opportunity to provide clinically effective, and high quality medications at decreased cost. This greater affordability may result in clinical benefits through wider and earlier therapy use. Also, the released funding can be used elsewhere in clinical care. With the proper monitoring and regulations in place, growing adoption of these biosimilars can be a significant approach in reducing budgets in healthcare and improving patient access to vital therapies and treatments. Market Segmentation The Global biosimiliar market has been segmented on the basis of product as recombinant non-glycosylated proteins, recombinant glycosylated proteins, recombinant peptides and others. Based on application the market has been segmented as oncology, blood disorder, chronic and auto immune disorder, infectious diseases and other application. Oncology segments commands the largest market share ad is expected to continue its growth in the coming future. Regional Analysis Europe with the maximum approval of these drugs commands the major market share. North America due to strict rules and regulations over the manufacturing of these drugs is expected to gain its market slowly in the coming future. Asia pacific is expected to be the fastest growing region due to the high occurrence of cancer and such disease and hence the need for such cheap alternative. Key Players The major companies that are working in the market include the big pharmaceutical giants such as Pfizer Inc., and Teva Pharmaceuticals. Both the companies have the successful record of biosimilar drugs in their product portfolio for cancer treatment. The legal requirements for the approval pathways and the costly manufacturing process further escalate the cost of developing these products. High cost not just act as the entry barrier for the new entries that are willing to produce the product but is also expected to delay the availability of inexpensive products for the public healthcare institutions that subsidized treatment for their patients. Latest News Late in November 2017, Pfizer launched Inflectra at a 15 % discount. Which not just increase the sales of the drug, but also proved to be a tough competition for the other rivals in the market. Europe has approved two more biosimilar drugs for cancer treatment in 2017 and around 5 more are waiting for the clinical trials and approval in 2018.

Table of Contents Introduction Market Definition Market Scope Limitations Market Overview Report segmentation and Scope Market Value Chain Analysis Key Trends Drivers Restraints Opportunities Porter’s Five Forces Analysis Potential Venture Avenues Market Share Analysis Segment 1 Introduction Market Size & Forecast, 2015 to 2025 Segment 1 Type A Segment 1 Type B Segment 1 Type C Segment 1 Type D Segment 1 Type E Segment 2 Introduction Market Size & Forecast, 2015 to 2025 Segment 2 Type A Segment 2 Type B Segment 2 Type C Segment 2 Type D Segment 2 Type E Regional Overview Introduction Market Size & Forecast, 2015 to 2025 North America US Canada Mexico Europe UK Germany France Italy Spain Rest of Europe Asia-Pacific China India Japan Australia South Korea Rest of Asia-Pacific LAMEA Brazil UAE South Africa Rest of the LAMEA Company Profile Company 1 Company Overview Financial Synopsis Recent Developments R&D Investments (if any) Strategy Overview (Analyst Perspective) Product Portfolio Company 2 Company 3 Company 4 Company 5 Company 6 Company 7 Company 8 Company 9 Company 10

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Biosimilars Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




7 + 4 =

 

Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Report ID :47131

Published Date :January, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports


Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology